Telcordia Technologies Inc.’s patent infringement suit against Tellabs, Inc., remains pending.
On May 4, 2009, Telcordia Technologies filed a complaint against Tellabs in the U.S. District Court for the District of…
Merck & Co. Inc. and Schering-Plough Corporation continue to pursue a patent infringement lawsuit against generic pharmaceutical manufacturers who filed abbreviated new drug applications for generic ezetimibe (Zetia).
An abbreviated new…
Teva Pharmaceuticals Inc. has appealed the decision upholding the validity of Merck & Co. Inc.’s Singulair patent.
On Aug. 19, 2009, the U.S. District Court for the District of New Jersey…
Merck & Co. Inc. continues to evaluate the information provided with an Abbreviated New Drug Application notice to determine what action should be taken.
In January 2009, the Company received notice…
The U.S. Patent and Trademark Office’s reexamination proceedings regarding Merck & Co. Inc.’s Singulair patent are ongoing.
In May 2009, the PTO granted a petition by Article One Partners LLC to…
Merck & Co. Inc.’s patent infringement lawsuits against generic pharmaceutical manufacturers who filed abbreviated new drug applications for its products.
Generic pharmaceutical manufacturers have submitted ANDA’s to the Food and Drug…
Medtronic Inc. and its subsidiary, Medtronic AVE, Inc. remain in dispute with Wyeth and Cordis Corporation over the alleged infringement of “Morris” patents.
On Feb. 22, 2008, Wyeth and Cordis Corporation…
Shire Ltd. is pursuing two suits against Nostrum Pharmaceuticals Inc. in the U.S. District Court for the District of New Jersey for the alleged infringement of U.S. Patent Nos. 5,912,013…
No trial date has been set for the litigation between Shire Ltd. and Apotex Inc., Apotex Corp. and Apotex Pharmaceutical Holdings Inc. for the alleged infringement of U.S. Patent Nos.…
A ruling on Merck & Co Inc.’s suit against Teva Pharmaceuticals Inc. in the U.S. District Court for the District of New Jersey for the alleged infringement of U.S. Patent…